Glucosamine Enhancement of BDNF Expression and Animal Cognitive Function

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Brain-derived neurotrophic factor (BDNF) is crucial for memory consolidation and cognitive processes.
• Protein kinase A (PKA) signaling pathways are intricately linked with BDNF's downstream effects.
• Glucosamine (GLN), a widely used dietary supplement, exhibits various physiological benefits.

Purpose of the Study:

• To investigate the effects of Glucosamine (GLN) on cognitive performance in mice.
• To elucidate the molecular mechanisms underlying GLN's potential cognition-enhancing effects.
• To determine if GLN influences BDNF levels and related signaling pathways.

Main Methods:

• In vivo study using C57BL/6 mice treated with varying doses of GLN, assessed via novel object recognition test.
• In vitro study using HT22 hippocampal cells to examine GLN's impact on BDNF, CREB5, and cAMP signaling.
• Analysis of hippocampal tissue and cell cultures for cAMP concentrations, CREB phosphorylation, and gene/protein expression.

Main Results:

• GLN administration significantly improved cognitive function in the novel object recognition test.
• In the hippocampus, GLN increased cAMP levels, CREB phosphorylation, BDNF, CREB5, and TrkB expression, while decreasing PDE4B.
• In vitro, GLN elevated BDNF and CREB5 levels and induced cAMP responsive element (CRE) reporter activity, effects blocked by a PKA inhibitor.

Conclusions:

• Glucosamine (GLN) demonstrates cognition-enhancing properties.
• GLN's effects are mediated, at least partly, by the upregulation of BDNF through a cAMP/PKA/CREB-dependent pathway.
• These findings suggest GLN as a potential therapeutic agent for cognitive enhancement.